Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $79.4100 (-1.37%) ($78.8000 - $80.1400) on Wed. Feb. 27, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.07% (three month average) | RSI | 54 | Latest Price | $79.4100(-1.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) VYM(50%) DIA(49%) IVE(49%) SPLV(49%) | Factors Impacting ABBV price | ABBV will decline at least -1.035% in a week (0% probabilities). TLT(-15%) UUP(-13%) VXX(-12%) VIXM(-11%) IFRA(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.035% (StdDev 2.07%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
Resistance Level | $79.88 | 5 Day Moving Average | $79.8(-0.49%) | 10 Day Moving Average | $80.15(-0.92%) | 20 Day Moving Average | $79.88(-0.59%) | To recent high | -14.7% | To recent low | 2.9% | Market Cap | $140.102b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |